Press Release

Nota AI Expands AI Optimization Technology into Space, Joins Development of Autonomous Space Biopharma Experiment System

June 25, 2026

Nota AI Expands AI Optimization Technology into Space, Joins Development of Autonomous Space Biopharma Experiment System
- Nota AI expands its AI optimization technology into space amid growing industry interest following Space X’s IPO
- Company to participate in development of an autonomous space biopharma experiment system for the ISS and other low-Earth-orbit micro gravity environments
- On-device AI compression and optimization technology to address c ommunications, power, and computing constraints in space

Nota AI, a company specializing in AI model compression and optimization led by CEO Myungsu Chae, announced that it will participate in the “Deep Tech Challenge Project (DCP) – Ecosystem Innovation Track,” led by Space LiinTech, and will be responsible for developing on-device AI optimization technology. Supported by the Ministry of SMEs and Startups and the Korea Technology and Information Promotion Agency for SMEs (TIPA), the four-year project is eligible for up to KRW 20 billion in funding.

SpaceLiinTech, the lead organization, is a space biopharma specialist that successfully demonstrated Korea’s first spacebiopharma research module aboard the International Space Station (ISS). The company has also accumulated experience in operating space-based research through the development of a space biosatellite. Through this project, Nota AI will expand the application of its AI optimization technology from terrestrial edge environments—including smartphones, automobiles, robots, and industrial equipment—into the space industry.

Following Space X’s recent record-setting initial public offering, global investor and industry interest in the broader space sector has continued to grow. The space industry is expanding beyondlaunch vehicles and satellites into applications that utilize the space environment, including biopharma, manufacturing, and data services. Spacebiopharma, in particular, is emerging as a next-generation field with significant growth potential.

Space biopharma leverages microgravity to explore new possibilities in protein structure research and biopharmaceutical manufacturing. On Earth, gravity-driven convection, sedimentation, and buoyancy can affect crystallization and mixing processes. Microgravity can reduce these effects, creating conditions that can benefit space-based biopharma research.

The project aims to validate biopharmaceutical structure research and manufacturing in the ISS and other low-Earth-orbit microgravity environments, while developing a pharmaceutical manufacturing system capable of autonomously managing experimental processes.It will also conduct demonstrations in which samples produced in space are returned to Earth for analysis, with the goal of expanding the platform for future use aboard commercial space stations.

Nota AI will develop on-device AI technology that enables the space experiment system to analyze data and assess experiment status locally. Using video and sensor data, the system will recognize experiment conditions, detect anomalies, and generate natural-language summaries for transmission to Earth. Nota AI will compress and optimize the AI models so they can perform these functions efficiently on resource-constrained hardware.

Communications, power, computing resources,and thermal capacity are highly constrained in space, making it impractical to transmit all data to Earth for analysis. Local AI capable of processing data and making assessments within the experiment system is therefore essential. Nota AI’s optimization technology, which enables AI models to run quickly and reliably on limited hardware, is expected to provide a core foundation for autonomous space experiment platforms. The project marks an expansion of Nota AI’son-device AI capabilities—from terrestrial edge environments such as mobile devices, autonomous driving, and robotics into space, one of the most demanding edge environments.

“Space is an extreme edge environment where communications, power, and computing resources are limited, requiring AI to operate locally,” said Myungsu Chae, CEO of Nota AI. “This is where the need for on-device AI optimization becomes especially clear.”

“This project represents an important milestone in extending the AI compression and optimization technologies Nota AI has developed into the space industry,” Chae added. “Guided by our AI Everywhere vision, we will continue strengthening our edge AI competitiveness to meet the unique demands of the space sector.”

Related